PCG
PFC Capital Group Portfolio holdings
AUM
$216M
1-Year Est. Return
13.1%
1 Year Est. Return
+13.1%
AUM
$216M
AUM Growth
+$17.7M
(+8.9%)
Holding
88
Top Buys
| 1 | +$2.35M | |
| 2 | +$1.5M | |
| 3 | +$1.28M | |
| 4 |
Avantis US Large Cap Value ETF
AVLV
|
+$1.26M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.26M |
Top Sells
| 1 | +$1.53M | |
| 2 | +$930K | |
| 3 | +$851K | |
| 4 |
Qualcomm
QCOM
|
+$684K |
| 5 |
Thermo Fisher Scientific
TMO
|
+$539K |
Sector Composition
| 1 | Technology | 39.21% |
| 2 | Consumer Staples | 10.23% |
| 3 | Consumer Discretionary | 9.2% |
| 4 | Communication Services | 6.24% |
| 5 | Financials | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Danaher
DHR
$157B
| $235K | 0.11% |
1,194
-1,740
|
|
||
77
Vanguard Total International Stock ETF
VXUS
$108B
| $226K | 0.1% |
+3,284
|
|
||
78
Boeing
BA
$165B
| $223K | 0.1% |
+1,066
|
|
||
79
TJX Companies
TJX
$158B
| $216K | 0.1% |
1,750
-250
|
|
||
80
Avantis Real Estate ETF
AVRE
$661M
| $22K | 0.01% |
500
|
|
||
81
Vanguard Value ETF
VTV
$149B
| $19K | 0.01% |
112
|
|
||
82
Vanguard Growth ETF
VUG
$199B
| $7K | ﹤0.01% |
18
|
|
||
83
AbbVie
ABBV
$403B
| – | – |
-1,060
|
|
||
84
Bristol-Myers Squibb
BMY
$89.2B
| – | – |
-5,436
|
|
||
85
DuPont de Nemours
DD
$34B
| – | – |
-4,075
|
|
||
86
Merck
MRK
$219B
| – | – |
-2,274
|
|
||
87
Schwab US Large- Cap ETF
SCHX
$61.9B
| – | – |
-149
|
|
||
|
88
Thermo Fisher Scientific
TMO
$216B
| – | – |
-1,085
|
|